Optimal Care Pathways for myelodysplastic syndromes (MDS)
Myelodysplastic syndromes (MDS, or myelodysplasia) are a group of blood cancers which all affect, to a greater or lesser extent, the production of normal blood cells in the bone marrow. MDS occurs as a result of a mutation (or change) in one or more of the genes that control blood cell development. This change or changes results in the abnormal growth of blood stem cells.
Disease-specific Guides to Best Cancer Care have been developed for the following diseases. The guides help people with cancer to understand the optimal cancer care they should be provided and support people to understand what might happen at each step of their cancer experience and consider what questions to ask.